All In Biotech

Drug Trial Radar · NCT07363642

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

TAPER: A Prospective, Interventional, Multicentre, Single-Arm, Phase 3b Study to Evaluate the Step-Down of Maintenance Therapy in Patients With Severe Asthma Treated With Tezepelumab

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Jan 28, 2026

Primary completion

Feb 7, 2028

Study completion Mar 31, 2029

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to explore the potential for Tezepelumab-treated severe asthmatic patients to effectively and safely reduce their background maintenance medication while maintaining asthma symptom control.

Conditions

  • Severe Asthma

Interventions

  • TezepelumabDrug

    Severe asthma taking medium-high dose ICS-LABA with up to one additional controller will be enrolled into this single arm treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the potential for Tezepelumab treated patients to reduce their standard of care asthma controller regimen in the overall patient population while maintaining asthma controlTime frame: within 36 weeks after the first administration
  2. To assess the potential for Tezepelumab treated patients to reduce their standard of care asthma controller regimen in the overall patient population while maintaining asthma controlTime frame: within 36 weeks after the first administration

Locations

75 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Recruiting

  • Research Site

    Beijing, China · Not yet recruiting

  • Research Site

    Binzhou, China · Recruiting

  • Research Site

    Changsha, China · Not yet recruiting

  • Research Site

    Changsha, China · Recruiting

  • Research Site

    Chengdu, China · Recruiting

  • Research Site

    Chengdu, China · Recruiting

  • Research Site

    Chengdu, China · Recruiting

  • Research Site

    Chengdu, China · Recruiting

  • Research Site

    Chongqing, China · Recruiting

  • Research Site

    Chongqing, China · Recruiting

  • Research Site

    Deyang, China · Recruiting

  • Research Site

    Fuzhou, China · Recruiting

  • Research Site

    Guangzhou, China · Not yet recruiting

  • Research Site

    Guangzhou, China · Not yet recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Guangzhou, China · Recruiting

  • Research Site

    Guiyang, China · Recruiting

  • Research Site

    Hangzhou, China · Recruiting

  • Research Site

    Hangzhou, China · Recruiting

  • Research Site

    Hangzhou, China · Recruiting

  • Research Site

    Hefei, China · Recruiting

  • Research Site

    Hefei, China · Recruiting

  • Research Site

    Hohhot, China · Recruiting

  • Research Site

    Jiangmen, China · Recruiting

  • Research Site

    Jinan, China · Recruiting

  • Research Site

    Jinan, China · Recruiting

  • Research Site

    Jinan, China · Recruiting

  • Research Site

    Jining, China · Recruiting

  • Research Site

    Kunming, China · Not yet recruiting

  • Research Site

    Leshan, China · Recruiting

  • Research Site

    Linyi, China · Recruiting

  • Research Site

    Luzhou, China · Recruiting

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.